Literature DB >> 8855306

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

Y M Li1, T Mitsuhashi, D Wojciechowicz, N Shimizu, J Li, A Stitt, C He, D Banerjee, H Vlassara.   

Abstract

Advanced glycation endproducts (AGEs) are derivatives of nonenzymatic reactions between sugars and protein or lipids, and together with AGE-specific receptors are involved in numerous pathogenic processes associated with aging and hyperglycemia. Two of the known AGE-binding proteins isolated from rat liver membranes, p60 and p90, have been partially sequenced. We now report that the N-terminal sequence of p60 exhibits 95% identity to OST-48, a 48-kDa member of the oligosaccharyltransferase complex found in microsomal membranes, while sequence analysis of p90 revealed 73% and 85% identity to the N-terminal and internal sequences, respectively, of human 80K-H, a 80- to 87-kDa protein substrate for protein kinase C. AGE-ligand and Western analyses of purified oligosaccharyltransferase complex, enriched rough endoplasmic reticulum, smooth endoplasmic reticulum, and plasma membranes from rat liver or RAW 264.7 macrophages yielded a single protein of approximately 50 kDa recognized by both anti-p60 and anti-OST-48 antibodies, and also exhibited AGE-specific binding. Immunoprecipitated OST-48 from rat rough endoplasmic reticulum fractions exhibited both AGE binding and immunoreactivity to an anti-p60 antibody. Immune IgG raised to recombinant OST-48 and 80K-H inhibited binding of AGE-bovine serum albumin to cell membranes in a dose-dependent manner. Immunostaining and flow cytometry demonstrated the surface expression of OST-48 and 80K-H on numerous cell types and tissues, including mononuclear, endothelial, renal, and brain neuronal and glial cells. We conclude that the AGE receptor components p60 and p90 are identical to OST-48, and 80K-H, respectively, and that they together contribute to the processing of AGEs from extra- and intracellular compartments and in the cellular responses associated with these pathogenic substances.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855306      PMCID: PMC38281          DOI: 10.1073/pnas.93.20.11047

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

Authors:  M Neeper; A M Schmidt; J Brett; S D Yan; F Wang; Y C Pan; K Elliston; D Stern; A Shaw
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

2.  Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia.

Authors:  S C Lee; W Liu; C F Brosnan; D W Dickson
Journal:  Lab Invest       Date:  1992-10       Impact factor: 5.662

3.  Pituitary epithelial cell implants reverse the accumulation of CD4-CD8- lymphocytes in thymus glands of aged rats.

Authors:  Y M Li; D L Brunke; R Dantzer; K W Kelley
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

Review 4.  Issues in searching molecular sequence databases.

Authors:  S F Altschul; M S Boguski; W Gish; J C Wootton
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

Review 5.  Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Authors:  H Vlassara; R Bucala; L Striker
Journal:  Lab Invest       Date:  1994-02       Impact factor: 5.662

6.  Purification and characterization of avian oligosaccharyltransferase. Complete amino acid sequence of the 50-kDa subunit.

Authors:  V Kumar; F S Heinemann; J Ozols
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

7.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

Authors:  S D Yan; A M Schmidt; G M Anderson; J Zhang; J Brett; Y S Zou; D Pinsky; D Stern
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

8.  Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.

Authors:  M Kirstein; C Aston; R Hintz; H Vlassara
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

9.  The 48-kDa subunit of the mammalian oligosaccharyltransferase complex is homologous to the essential yeast protein WBP1.

Authors:  S Silberstein; D J Kelleher; R Gilmore
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

10.  Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.

Authors:  T Doi; H Vlassara; M Kirstein; Y Yamada; G E Striker; L J Striker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more
  75 in total

Review 1.  [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].

Authors:  P P Nawroth; A Bierhaus; G E Vogel; M A Hofmann; M Zumbach; P Wahl; R Ziegler
Journal:  Med Klin (Munich)       Date:  1999-01-15

Review 2.  Advanced glycation: an important pathological event in diabetic and age related ocular disease.

Authors:  A W Stitt
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

Review 3.  Innovative techniques and applications in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2003-11-28       Impact factor: 4.304

Review 4.  Glycoxidation and diabetic complications: modern lessons and a warning?

Authors:  Helen Vlassara; Jaime Uribarri
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

5.  Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells.

Authors:  Changyong Lu; John Cijiang He; Weijing Cai; Huixian Liu; Li Zhu; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

Review 6.  Trends in advanced glycation end products research in diabetes mellitus and its complications.

Authors:  José D Méndez; Jianling Xie; Montserrat Aguilar-Hernández; Verna Méndez-Valenzuela
Journal:  Mol Cell Biochem       Date:  2010-03-23       Impact factor: 3.396

Review 7.  Oxidative stress in diabetic nephropathy.

Authors:  N Kashihara; Y Haruna; V K Kondeti; Y S Kanwar
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

8.  Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs.

Authors:  A W Stitt; C He; S Friedman; L Scher; P Rossi; L Ong; H Founds; Y M Li; R Bucala; H Vlassara
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

9.  Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells.

Authors:  C B Renard; B Askari; L A Suzuki; F Kramer; K E Bornfeldt
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

10.  Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study.

Authors:  B K Kilhovd; A Juutilainen; S Lehto; T Rönnemaa; P A Torjesen; K F Hanssen; M Laakso
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.